In conjunction with the North American Neuro-Ophthalmology Society (NANOS)
When Should I Worry? Concerning Signs, Symptoms, and Findings in Neuro-Ophthalmology
Friday, Nov. 3
Moscone Center, San Francisco, CA
Peter A. Quiros, MD and Madhura A. Tamhankar, MD
Program Planning Group
Eric L. Berman MD, Chantal Boisvert MD, John J. Chen, MD, PhD, Michael Dattilo MD, Kathleen B. Digre MD, Valerie I. Elmalem MD, Courtney E. Francis MD, Kimberly K. Gokoffski MD, Lynn K. Gordon MD PhD, Guy V. Jirawuthiworavong MD, Sachin Kedar MD, Andrew G. Lee MD , Collin M. McClelland MD, Andrew Melson, MD, Jason H. Peragallo MD, Peter A. Quiros MD, Madhura A. Tamhankar MD
The mission of the 2023 AAO-NANOS Neuro-Ophthalmology Subspecialty Day is to provide new, updated, and clinically relevant neuro-ophthalmic information that will assist the practicing ophthalmologist to identify critical findings and to differentiate them from potential distractors to make an accurate diagnosis and determine management strategies based on best practices.
The intended audience for this program is comprehensive ophthalmologists.
Beginner, intermediate, and advanced concepts will be discussed to offer sufficient breadth and depth to the target audience.
By the conclusion of this symposium, the attendee will recognize neuro-ophthalmic signs or symptoms, interpret them correctly to arrive at an accurate diagnosis, and be able to determine appropriate initial management based on best practices.
Upon completion of this activity, participants should be able to:
- Recognize neuro-ophthalmic side effects of systemic medications.
- Differentiate the etiology of visual loss in those presenting with optic disc edema due to different causes.
- Characterize symptoms such as photophobia, dysphotopsia, and hemeralopia as it can mimic neuro-ophthalmic disease.
- Formulate hypotheses for patients who present with failure of visual improvement after cataract surgery that may harbor a potential neuro-ophthalmic condition.
- Interpret crucial pre-operative examination findings that can help diagnose such patients to avoid poor outcomes after cataract surgery.